Answers are grounded in this paper and cite their sources.
Dihydrolipoamide dehydrogenase (E3) (dihydrolipoam ide: NAD+ oxidoreductase; EC 1.8.1.4)is an essential com ponent in three a-keto acid dehydrogenase complexes (pyruvate, a-ketoglutarate and branched-chain a-keto acid dehydrogenase complexes)1 and the glycine cleavage system.2E3 facilitates the reoxidation of the dihydrolipoyl prosthetic group of the acyltransferase components of the three a-keto acid dehydrogenase complexes and of the hydrogen-car rier protein of the glycine cleavage system.The decrease of the E3 activity can affect the activities of all three com plexes, because E3 is commonly present in them.This results in increased urinary excretion of a-keto acids, ele vated blood lactate, pyruvate, and branched chain amino acids.Patients with an E3 deficiency normally die young, because it is a critical genetic defect that affects parts of the central nervous system, such as the brain, which leads to serious diseases, including Leigh syndrome with per manent lactic acidaemia and mental retardation.3E3 exists as a homodimeric form containing one FAD as a prosthetic group at each subunit (Fig. 1).4Each subunit
No takes yet. Share an insight, caveat, or question.
Hakjung Kim (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: